Parallel Atrophy of Cortex and Basal Forebrain Cholinergic System in Mild Cognitive Impairment

Abstract The basal forebrain cholinergic system (BFCS) is the major source of acetylcholine for the cerebral cortex in humans. The aim was to analyze the pattern of BFCS and cortical atrophy in MCI patients to find evidence for a parallel atrophy along corticotopic organization of BFCS projections. BFCS volume and cortical thickness were analyzed using high‐definition 3D structural magnetic resonance imaging data from 1.5‐T and 3.0‐T scanners of 64 MCI individuals and 62 cognitively healthy elderly controls from the European DTI study in dementia. BFCS volume reduction was correlated with thinning of cortical areas with known BFCS projections, such as Ch2 and parahippocampal gyrus in the MCI group, but not in the control group. Additionally, we found correlations between BFCS and cortex atrophy beyond the known corticotopic projections, such as between Ch4p and the cingulate gyrus. BFCS volume reduction was associated with regional thinning of cortical areas that included, but was not restricted to, the pattern of corticotopic projections of the BFCS as derived from animal studies. Our in vivo results may indicate the existence of more extended projections from the BFCS to the cerebral cortex in humans than that known from prior studies with animals.

[1]  M. Catani,et al.  The arcuate fasciculus and the disconnection theme in language and aphasia: History and current state , 2008, Cortex.

[2]  A. Dale,et al.  Regional and progressive thinning of the cortical ribbon in Huntington’s disease , 2002, Neurology.

[3]  A. Levey,et al.  Cholinergic innervation of cortex by the basal forebrain: Cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (Substantia innominata), and hypothalamus in the rhesus monkey , 1983, The Journal of comparative neurology.

[4]  G. Wilcock,et al.  The cholinergic hypothesis of Alzheimer’s disease: a review of progress , 1999, Journal of neurology, neurosurgery, and psychiatry.

[5]  M. Mesulam,et al.  Central cholinergic pathways in the rat: An overview based on an alternative nomenclature (Ch1–Ch6) , 1983, Neuroscience.

[6]  I. Kostović,et al.  Nucleus subputaminalis (ayala): the still disregarded magnocellular component of the basal forebrain may be human specific and connected with the cortical speech area , 1999, Neuroscience.

[7]  E. Mufson,et al.  Cholinergic Basal Forebrain Systems in the Primate Central Nervous System: Anatomy, Connectivity, Neurochemistry, Aging, Dementia, and Experimental Therapeutics , 2001 .

[8]  A. Dale,et al.  Thinning of the cerebral cortex in aging. , 2004, Cerebral cortex.

[9]  R. Petersen.  Mild cognitive impairment as a diagnostic entity , 2004, Journal of internal medicine.

[10]  Anders M. Dale,et al.  Improved Localization of Cortical Activity By Combining EEG and MEG with MRI Cortical Surface Reconstruction , 2002 .

[11]  H. Hanyu,et al.  MR analysis of the substantia innominata in normal aging, Alzheimer disease, and other types of dementia. , 2002, AJNR. American journal of neuroradiology.

[12]  J. Whitwell,et al.  Alzheimer's disease neuroimaging , 2018, Current opinion in neurology.

[13]  Anders M. Dale,et al.  Cortical Surface-Based Analysis I. Segmentation and Surface Reconstruction , 1999, NeuroImage.

[14]  P. Davies,et al.  SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE , 1976, The Lancet.

[15]  J. Kehr,et al.  Galanin regulates the postnatal survival of a subset of basal forebrain cholinergic neurons. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[16]  R. Nieuwenhuys,et al.  Cell loss and shrinkage in the nucleus basalis Meynert complex in Alzheimer's disease , 1990, Neurobiology of Aging.

[17]  R. Mohs,et al.  Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease. , 2002, Psychopharmacology bulletin.

[18]  Juha Koikkalainen,et al.  Differences in cortical thickness in healthy controls, subjects with mild cognitive impairment, and Alzheimer's disease patients: a longitudinal study. , 2010, Journal of Alzheimer's disease : JAD.

[19]  H. Heinsen,et al.  Atrophy of the Cholinergic Basal Forebrain Over the Adult Age Range and in Early Stages of Alzheimer's Disease , 2012, Biological Psychiatry.

[20]  Stefan J. Teipel,et al.  Brain atrophy in primary progressive aphasia involves the cholinergic basal forebrain and Ayala's nucleus , 2014, Psychiatry Research: Neuroimaging.

[21]  A. Simmons,et al.  Entorhinal cortex thickness predicts cognitive decline in Alzheimer's disease. , 2013, Journal of Alzheimer's disease : JAD.

[22]  Alan C. Evans,et al.  Spatial patterns of cortical thinning in mild cognitive impairment and Alzheimer's disease. , 2006, Brain : a journal of neurology.

[23]  Maija Pihlajamäki,et al.  Structural and functional MRI in mild cognitive impairment. , 2009, Current Alzheimer research.

[24]  K. Amunts,et al.  Reduction of basal forebrain cholinergic system parallels cognitive impairment in patients at high risk of developing Alzheimer's disease. , 2010, Cerebral cortex.

[25]  Nick C Fox,et al.  Patterns of cortical thinning in the language variants of frontotemporal lobar degeneration , 2009, Neurology.

[26]  Marianna D. Eddy,et al.  Regionally localized thinning of the cerebral cortex in schizophrenia , 2003, Schizophrenia Research.

[27]  H. Vankova.  Mini Mental State , 2010 .

[28]  John Ashburner,et al.  A fast diffeomorphic image registration algorithm , 2007, NeuroImage.

[29]  Anders M. Dale,et al.  Automatic parcellation of human cortical gyri and sulci using standard anatomical nomenclature , 2010, NeuroImage.

[30]  J. Parker,et al.  Amyloid deposition in Alzheimer's disease. , 1993, Annals of clinical and laboratory science.

[31]  A M Dale,et al.  Measuring the thickness of the human cerebral cortex from magnetic resonance images. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[32]  A. Levey,et al.  Alterations in Cortical Thickness and White Matter Integrity in Mild Cognitive Impairment Measured by Whole-Brain Cortical Thickness Mapping and Diffusion Tensor Imaging , 2009, American Journal of Neuroradiology.

[33]  H. Braak,et al.  Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry , 2006, Acta Neuropathologica.

[34]  H. Möller,et al.  Measurement of basal forebrain atrophy in Alzheimer's disease using MRI. , 2005, Brain : a journal of neurology.

[35]  T. Arendt,et al.  Amyloid deposition in the nucleus basalis of Meynert complex: a topographic marker for degenerating cell clusters in Alzheimer's disease , 2004, Acta Neuropathologica.

[36]  C. Broere,et al.  Galanin-like immunoreactivity within Ch2 neurons in the vertical limb of the diagonal band of Broca in aging and Alzheimer's disease , 2004, Acta Neuropathologica.

[37]  J. Ashburner,et al.  Nonlinear spatial normalization using basis functions , 1999, Human brain mapping.

[38]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[39]  B. Winblad,et al.  Mild cognitive impairment in the general population: occurrence and progression to Alzheimer disease. , 2008, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[40]  D. Amaral,et al.  Functional Neuroanatomy of the Medial Temporal Lobe Memory System , 2004, Cortex.

[41]  Anderson M. Winkler,et al.  Cortical thickness or grey matter volume? The importance of selecting the phenotype for imaging genetics studies , 2010, NeuroImage.

[42]  T. Robbins,et al.  Distribution and some projections of cholinergic neurons in the brain of the common marmoset, Callithrix jacchus , 1988, The Journal of comparative neurology.

[43]  M. Mesulam,et al.  Trajectories of cholinergic pathways within the cerebral hemispheres of the human brain. , 1998, Brain : a journal of neurology.

[44]  Claude Lepage,et al.  Mapping reliability in multicenter MRI: Voxel‐based morphometry and cortical thickness , 2010, Human brain mapping.

[45]  E. Mufson,et al.  Loss of nerve growth factor receptor-containing neurons in Alzheimer's disease: A quantitative analysis across subregions of the basal forebrain , 1989, Experimental Neurology.

[46]  W. Benzing,et al.  Galaninergic innervation of the cholinergic vertical limb of the diagonal band (Ch2) and bed nucleus of the stria terminalis in aging, Alzheimer's disease and Down's syndrome. , 1993, Dementia.

[47]  R. Stine.  Graphical Interpretation of Variance Inflation Factors , 1995 .

[48]  Stefan Klöppel,et al.  Subregional basal forebrain atrophy in Alzheimer's disease: a multicenter study. , 2014, Journal of Alzheimer's disease : JAD.

[49]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[50]  M. Garcia-Alloza,et al.  Evaluation of cholinergic markers in Alzheimer's disease and in a model of cholinergic deficit , 2005, Neuroscience Letters.

[51]  M. Mesulam,et al.  Cholinergic nucleus basalis tauopathy emerges early in the aging‐MCI‐AD continuum , 2004, Annals of neurology.

[52]  Harald Hampel,et al.  The cholinergic system in mild cognitive impairment and Alzheimer's disease: An in vivo MRI and DTI study , 2011, Human brain mapping.

[53]  Anders M. Dale,et al.  Reliability of MRI-derived measurements of human cerebral cortical thickness: The effects of field strength, scanner upgrade and manufacturer , 2006, NeuroImage.

[54]  Marie Chupin,et al.  Automatic classi fi cation of patients with Alzheimer ' s disease from structural MRI : A comparison of ten methods using the ADNI database , 2010 .